Summary
Insulin-dependent diabetic (IDDM) patients with diabetic nephropathy have a highly increased morbidity and mortality from coronary heart disease. An insertion (I) /deletion (D) polymorphism in the angiotensin-I-converting enzyme (ACE) gene has been shown to be associated with coronary heart disease. Therefore, we have investigated the role of this ACE/ID polymorphism in 198 IDDM patients with diabetic nephropathy and 190 normoalbuminuric IDDM patients. The prevalence of myocardial infarction and other coronary heart disease was significantly elevated in patients with nephropathy, 19% (38/198) vs 8% (15/190), p < 0.001. In the nephropathic group 12 of 63 (19%), 23 of 95 (24%), and 3 of 40 (7.5 %) patients with the DD, ID and II genotypes, respectively had a history of coronary heart disease, II vs DD and ID, p < 0.05 when compared to nephropathic patients without coronary heart disease. Multiple logistic regression analysis of the risk factors associated with coronary heart disease in univariate analysis revealed that the II genotype acts as an independent protective factor against coronary heart disease, odds ratio II/DD + ID 0.27 (95 % confidence interval 0.07–0.97, p < 0.05). There was no difference in genotype or allele frequency (D/I) between patients with and without nephropathy, 0.56/0.44 in both groups, but plasma ACE concentration was elevated in patients with nephropathy 609 (151–1504) ng/ml as compared to patients with normoalbuminuria, 428 (55–1630) ng/ml, p < 0.001. We suggest that ACE/ID polymorphism may influence the frequency of life-threatening cardiac complications in IDDM patients suffering from diabetic nephropathy, a condition characterized by increased plasma ACE concentration.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- ACE:
-
angiotensin-I-converting enzyme
- ACE/ID gene:
-
insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene
- CHD:
-
coronary heart disease.
- PCR:
-
polymerase chain reaction
References
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501
Borch-Johnsen K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 294: 1651–1654
Jensen T, Stender S, Deckert T (1988) Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin- dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31: 142–145
Hallab M, Bled F, Ebran JM et al. (1992) Elevated serum angiotensin I converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 29: 82–85
van Dyk J, Erman A, Erman F, Chen-Gal B, Sulkes J, Boner G (1994) Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications. Eur J Clin Invest 24: 463–467
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343–1346
Cambien F, Poirier O, Lecerf L et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644
Ruiz J, Blanché H, Cohen N et al. (1994) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci 91: 3662–3665
Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R (1993) Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085–1086
Raynolds MV, Bristow MR, Bush EW et al. (1993) Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342: 1073–1075
Parving H-H, Andersen AR, Smidt UM, Svendsen PAa (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i: 1175–1179
Danilov S, Jaspard E, Churakova T et al. (1994) Structure function analysis of angiotensin I converting enzyme using monoclonal antibodies. J Biol Chem 269(43):26806–26814
Sambrook J, Fritsch EF, Maniatis T (1991) Molecular cloning: A laboratory manual. 2nd edn. Cold Spring Harbor Laboratory Press, Plainview, New York
Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidylcarboxy peptidose 1). Nucleic Acids Res 20: 1433
Rose GA, Blackburn H (1968) Cardiovascular survey methods. 1st edn. World Health Organization, Geneva, pp 1–188
Blackburn H, Keys A, Sominson E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies: a classification system. Circulation 21: 1160–1175
Rose GA (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 27: 645–658
Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539–544
Katterman R, Jaworek D, Möller G (1984) Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Biochem 22: 245–251
Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH (1991) Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098–1104
Schelling P, Fischer H, Ganten D (1991) Angiotensin and cell growth: a link to cardiovascular hypertrophy. J Hypertens 9: 3–15
Tiret L, Kee F, Poirier O et al. (1993) Deletion polymorphism in the angiotensin-converting-enzyme is associated with a parenteral history of myocardial infarction. Lancet 341: 991–992
Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel J-M (1992) Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature 1: 72–75
Marre M, Bernadet P, Gallois Y et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384–388
Nomura H, Koni I, Michishita Y, Morise T, Takeda R (1994) Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 343: 482–483
Schunkert H, Hense H-W, Holmer SR et al. (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330: 1634–1638
Meade TW, Cooper JA, Peart WS (1993) Plasma renin activity and ischemic heart disease. N Engl J Med 329: 616–619
Pfeffer MA, Braunwald E, Moyé LA et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677
Yusuf S, Pepine CJ, Garces C et al. (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340: 1173–1178
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828
Ohishi M, Fujii K, Minammo T et al. (1993) A potent genetic risk factor for restenosis. Nature 5: 324–325
Evans A, Poirier O, Kee F et al. (1994) Polymorphisms of the angiotensin-converting-enzyme gene in subjects who died from coronary heart disease. Q J Med 87: 211–214
Bohn M, Berge KE, Bakken A, Erikssen J, Berg K (1993) Insertion/deletion (I/D) polymorphism at the locus for angiotensin I- converting enzyme and myocardial infarction. Clin Genetics 44: 292–297
Bohn M, Berge KE, Bakken A, Erikssen J, Berg K (1993) Insertion/seletion (I/D) polymorphism at the locus for angiotensin I- converting enzyme and parental history of myocardial infarction. Clin Genetics 44: 298–301
Morris BJ, Zee RYL, Schrader AP (1994) Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 94: 1085–1089
Tarnow L, Cambien F, Rossing P et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin- I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tarnow, L., Cambien, F., Rossing, P. et al. Insertion/deletion polymorphism in the angiotensin-l-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38, 798–803 (1995). https://doi.org/10.1007/s001250050355
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050355